CHOLESTOSOME
DEAD

Serial Number

87158910

Owner

TheraHoldings AG

Attorney

R. Neil Sudol

Filing Date

Sep 1, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CHOLESTOSOME Trademark

Serial Number: 87158910

CHOLESTOSOME is a trademark filed by TheraHoldings AG on September 1, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

TheraHoldings AG (2 trademarks)

Giessenstrasse 41
8835 Feusisberg , CH

Entity Type: 03

Trademark Details

Filing Date

September 1, 2016

Registration Date

Not Registered

Published for Opposition

January 31, 2017

Goods & Services

Pharmaceutical preparations for Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of any or all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, and cancers of all types, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), ankylosing spondylitis and vaccines and vaccination to prevent or treat infectious diseases and cancer; pharmaceutical preparations, namely, lipid vesicles encapsulating pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of any or all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, and cancers of all types, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), ankylosing spondylitis and vaccines and vaccination to prevent or treat infectious diseases and cancer; pharmaceutical preparations, namely, vesicles made of cholesteryl ester and containing pharmaceuticals for use in the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of any or all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, and cancers of all types, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), ankylosing spondylitis, and vaccines and vaccination to prevent or treat infectious diseases and cancer

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Oct 29, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 29, 2018 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 20, 2018 EXRA
SOU EXTENSION 2 GRANTED
Mar 16, 2018 EX2G
SOU EXTENSION 2 FILED
Mar 16, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 16, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 5, 2017 EXRA
SOU EXTENSION 1 GRANTED
Sep 1, 2017 EX1G
SOU EXTENSION 1 FILED
Sep 1, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 1, 2017 EEXT
ASSIGNED TO EXAMINER
May 1, 2017 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 28, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 31, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jan 31, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 11, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 19, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 14, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 14, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 14, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 14, 2016 CNEA
ASSIGNED TO EXAMINER
Dec 10, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2016 NWOS
NEW APPLICATION ENTERED
Sep 5, 2016 NWAP